ATS 2019 Virtual Final Program

• learn more about the ways in which correlating clinical and genomics data in MVP may be used to characterize subgroups of Veterans with lung cancer. In the VA’s Million Veteran Program (MVP), data from surveys, electronic medical records (EMR), and genomic studies have been obtained from over 650,000 Veterans. The goal is to improve understanding of genetic influences on cause, prevention and treatment of specific diseases. Safeguards to protect patient identities have been used throughout. This session will describe information for pulmonary investigators on applying for research support from the VA for studies related to MVP, on development of algorithms to identify patients with specific lung diseases from the VA EMR, and on results from MVP correlating clinical findings and genomic data in lung cancer. Chairing: J.K. Brown, MD, San Francisco, CA E. Garshick, MD, West Roxbury, MA M. Moy, MD, MSc, Boston, MA 12:15 Million Veteran Program: What You Need To Know S. Muralidhar, PhD, Washington, DC 12:45 Pulmonary Phenotyping Using the VA Electronic Medical Record E.S. Wan, MD, MPH, Boston, MA 1:00 Early and Late Stage Lung Cancer: Correlating Clinical Data and Genomics in MVP A. Zimolzak, MD, MMSc, Houston, TX NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH L13 UPDATE ON CLASSIFICATION OF CHEST RADIOGRAPHS AND THE B READER PROGRAM 12:15 p.m. - 1:15 p.m. KBHCCD Ballroom D One (Level 3) Target Audience Providers of clinical, research, administrative and legal services to individuals with suspected or known dust-induced lung disease (pneumoniosis) or with exposures putting them at risk for pneumoconiosis. Objectives At the conclusion of this session, the participant will be able to: • recognize what an ILO classification is, when it needs to be obtained, and the meaning of classification results; • learn what a B Reader is, why B Readers are important, and how to become a B Reader; • learn about new study materials to prepare for the B Reader Certification Examination and the availability of a chest digital image repository containing chest images potentially useful for teaching and research. The International Labour Organization (ILO) maintains an international system for classifying chest radiographs for the presence and severity of changes associated with dust-induced interstitial lung disease (pneumoconiosis). This session will describe the ILO classification system and current efforts to update it. It will also provide an update on the National Institute for Occupational Safety and Health (NIOSH) B Reader Program, which provides opportunities to learn about the ILO classification system and certification testing to document the ability to use it. Attendees will also learn about updates to B Reader training materials and the B Reader certification examination. Chairing: D.N. Weissman, MD, ATSF, Morgantown, WV 12:15 Chair Introduction D.N. Weissman, MD, ATSF, Morgantown, WV 12:18 International Effort to Update the ILO Classification System C.N. Halldin, PhD, Morgantown, WV 12:37 Overview of the NIOSH B Reader Certification Program A.S. Laney, PhD, Morgantown, WV 12:56 Developing an Updated B Reader Training Syllabus and Certification Examination R.A. Cohen, MD, Chicago, IL NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH L14 ASTHMA PREDICTION: NEW FINDINGS FROM COHORTS 12:15 p.m. - 1:15 p.m. KBHCCD Ballroom D Two (Level 3) Target Audience Providers of asthma and/or pediatric care, Researchers in asthma or public health Objectives At the conclusion of this session, the participant will be able to: • Learn about a new asthma risk score developed from birth cohorts. • Improve understanding of how the gut microbiome influences the risk of asthma • Learn new findings of how the risks for asthma are different or similar for urban and rural children. This session will present the latest research on risk factors that help determine whether a child will develop asthma. Chairing: H. Kim, MD, Detroit, MI J. Biagini Myers, PhD, Cincinnati, OH 12:15 The Interplay Between Maternal Factors and the Infant Gut Microbiota: Influence on the Risk for Allergic Asthma C.C. Johnson, PhD, MPH, Detroit, MI 12:34 Risk Factors for Respiratory Infections and Asthma Phenotypes in Rural and Urban Birth Cohorts J.E. Gern, MD, Madison, WI 12:53 Personalized Asthma Risk Score from CCAAPS and the Isle of Wight J. Biagini Myers, PhD, Cincinnati, OH ATS 2019 • Dallas, TX MONDAY • MAY 20 193 MONDAY MID-DAY